Oncolytic coxsackievirus therapy (Viralytics)

N/A

Report date: 2025/06/11 10:24:53

Base Information

Drug NameOncolytic coxsackievirus therapy (Viralytics)
Drug Alias NameCoxsackievirus A18 (Viralytics)Coxsackievirus A13 (Viralytics)Coxsackievirus A15 (Viralytics)CVA13CVA18 +[6] 
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionIntercellular adhesion molecule-1 modulatorsApoptosis stimulantsImmunostimulants
TargetsIntercellular adhesion molecule-1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesViralytics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesViralytics Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A